Tai Sandi See

Insider Reports History

Entity
Individual
Location
345 Park Avenue South, Floor 6, New York, NY
Signature
/s/ Jenny Robertson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tai Sandi See:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Development Officer Common Stock 16.6K $220K $13.22 Feb 5, 2024 Direct

Insider Reports Filed by Tai Sandi See

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXEO Lexeo Therapeutics, Inc. Feb 5, 2024 0 $0 3 Feb 6, 2024 Chief Development Officer